StoneWise
Founded in 2018, StoneWise is a frontier AI technology company dedicated to revolutionizing drug discovery by integrating cutting-edge artificial intelligence with deep pharmaceutical expertise.
At the heart of our innovation lies a multimodal 3D molecular generation model built upon the GPT/Transformer framework and enhanced with geometric deep learning algorithms, which combines breakthroughs in fundamental AI-driven drug development theories, robust data governance in pharmaceutical research, deep industry expertise, and strong software engineering capabilities.
This model has already delivered significant results across multiple pharmaceutical projects, some of which have advanced to clinical stages. Additionally, the model can serve as a foundational platform, enabling partners to integrate their proprietary data and models for customized iterations.
Our Mission
Expanding the Boundaries of Life Finding cures for Every Disease
Our Vision
Define New Paradigm for Faster and Better Drug Discovery
Investment Partners
Our Team
Zhou Jielong Founder & CEO
Master Degree of Artificial Intelligence, Beijing Institute of Technology
Mr. Zhou Jielong was Baidu’s former Principal Architect, and was responsible for application of machine learning technologies into Baidu’s core business, including core page ranking, anti-spam, cloud-based voice search and image search algorithms.
He led the team to re-frame Baidu’s search engine with machine learning algorithms, and made innovative efforts in a few AI fields, including AI system, AI expandability, and AI robustness.. He was also committed to improve the long-tail search experience, as well as search efficiency.
In 2013, he led the team to successfully apply deep learning to search engine for the first time in the world.
In recent years, he has been exploring in the field of AI + medicine and has provided unique insights on the field of AI + new drug research and development
Core Team
